亚洲社会药学

本期目录

2014年, 第9卷, 第4期　刊出日期：2014-12-20 上一期    下一期

论文

Select

Marine Pharmaceutical Industry Development inDeveloped Countries and Its Enlightenment ZHANG LI-jun;HUANG Tai-kang; 2014 (4):  161-165.  doi: 摘要 ( 542 )   Objective To provide references for marine pharmaceutical industry development in China by analyzing the development modes of marine pharmaceutical industry in developed countries. Methods Comparative study was conducted. Results and Conclusion Experiences of marine pharmaceutical industry development in the US, Japan and the EU are discussed, and the enlightenment to marine pharmaceutical industry in China is analyzed. 相关文章 | 计量指标

Select

Pharmacovigilance System for Pharmaceutical Enterprises in EU:Regulation and Its Enlightenment ZHANG Hao;LIU Si-qi;WU Zhi-ang 2014 (4):  166-170.  doi: 摘要 ( 488 )   Objective To provide references for China’s pharmaceutical enterprises by studying the pharmacovigilance system in EU, which is one of the most advanced and comprehensive monitoring system. Methods The contents and methods of pharmacovigilance system for pharmaceutical enterprises in EU were introduced based on the framework of social regulation. Results and Conclusion The social regulations of pharmacovigilance system include the set up of qualification system, information disclosure system and certification system. Establishing a scientific and reasonable pharmacovigilance system is an important measure for the government to control the drug risks and it is also an effective way to ensure drug safety after listing. 相关文章 | 计量指标

Select

Study on the Establishment of Efficiency Evaluation System of DrugSupervision and Sampling Test TAN Yi-ping;ZHANG Hao;YANG Yue 2014 (4):  171-177.  doi: 摘要 ( 506 )   Objective To set up the evaluation system for evaluating the efficiency of drug supervision and sampling test, to improve drug sampling test level, to make them targeted, applicable, rational and scientific. Methods Literature review was conducted to study related issues that may influence the efficiency of drug supervision and sampling test. Results and Conclusion 10 indicators of the drug sampling process and drug sampling results are put forward, including testing mechanism, testing management, testing capabilities, testing targeted, testing coverage and the hit rate of drug sampling to set up a complete standard score system. The establishment of a scientific and rational evaluation system of drug supervision and sampling test will improve the efficiency of drug sampling test. 相关文章 | 计量指标

Select

New Version of GDP in EU and Its Enlightenment ZHAO Shuang-chun;;CHEN Yu-wen;ZHAO Hong-ju 2014 (4):  178-181.  doi: 摘要 ( 471 )   Objective To provide a brief introduction on the new version of GDP in EU and to analyze its enlightenment. Methods Documents analysis and comparative study were conducted. Results and Conclusion The amendment to the version of GDP in EU is conducive to drug quality assurance. Some contents such as self-inspection, quality risk management and validation can provide some enlightenment. 相关文章 | 计量指标

Select

FDA Practices: GMP Quality System Inspection and Evaluation LI Yu-dan;YANG Yue 2014 (4):  182-186.  doi: 摘要 ( 509 )   Objective To regulate and guide pharmaceutical manufacturers to set up a better quality system and to ensure drug safety by studying FDA practices with ICH Q10 and 483 warning letters. Methods FDA practices at the inspection and evaluation were studied through literature review and statistical analysis methods. Results and Conclusion FDA attaches importance to the construction of inspection team during the evaluation process and focuses on the establishment of written procedures and process control with corrective and preventive measures. 相关文章 | 计量指标

Select

Family Economic Risk Caused by Five Major ChronicDiseases among Urban Residents: A Comparative StudyBased on the Data from 9 Cities in China LIU Ming;SUN Li-hua 2014 (4):  187-192.  doi: 摘要 ( 489 )   Objective To provide evidence of family economic risk caused by five major chronic diseases for medical insurance and health policy making. Methods The adjusted RR values of relative economic risk were applied to compare the family economic risks caused by five major chronic diseases. Results and Conclusion Among sample groups with five major chronic diseases respectively, those with cardiovascular disease have the highest family economic risk, which is 2.4 times than the average. Hypertensive people is 1.7 times, which has the lowest risk. People with chronic lung disease are 2.3 times, the diabetic people are 2.1 times, and people with arthritis or rheumatism are 2.0 times. Medical insurance should increase the proportion of reimbursement to reduce the medical expenditure for people who have high family economic risk caused by chronic diseases. 相关文章 | 计量指标

Select

Three Therapeutic Regimens in Treatment of Community-acquiredPneumonia: A Cost-effectiveness Analysis DONG Hong-yan;SUN Li-hua 2014 (4):  193-196.  doi: 摘要 ( 772 )   Objective To evaluate economic effectiveness of 3 therapeutic regimens in treatment of community-acquired pneumonia, and to provide references for rational drug use and optimal regimen. Methods A retrospective study was conducted with 117 clinical cases of community-acquired pneumonia. Cost-effectiveness analysis of cefmetazole sodium (therapy A n=60), erythromycin (therapy B=28), cefmetazole sodium and erythromycin (therapy C=29) for community-acquired pneumonia were carried out. Results and Conclusion Effective rates of 3 therapeutic regimens were 51.67%, 60.71%, 65.52%, total cost were RMB 3195.01, 2964.80, 3661.56, respectively; cost-effectiveness ratio were 61.83, 48.84, 55.88; incremental cost effectiveness ratio of A and C, B and C is 33.69, 144.86, respectively. Therapy B and C are superior to therapy A for community-acquired pneumonia, while the economic effectiveness of B and C cannot be determined. 相关文章 | 计量指标

Select

An Analysis of Marketing Channels of Biological Reagentsin China and Canada BAI Jian;;MIAO Lan-ying;LIN Da-yong;WANG Hai-bo;LI Ye 2014 (4):  197-199.  doi: 摘要 ( 459 )   Objective To provided references for the development of marketing channels of biological reagents in China by comparing the marketing channels between China and Canada. Methods Marketing channel length, e-commerce pattern and third-party logistics service, marketing channels in China and Canada were analyzed, and problems of marketing channels of biological reagents in China were discussed. Results and Conclusion Biological reagents enterprises in China can learn the experience from Canada to improve the efficiency of marketing channels of reagents by developing flat sales channel structure, optimizing the supply chains and accelerating e-commerce application. 相关文章 | 计量指标

Select

Foreign Online Pharmacies: Diversification and Its Enlightenment MENG Ling-quan;WU Zhi-ang;ZHOU Ying 2014 (4):  200-204.  doi: 摘要 ( 543 )   Objective To provide references for online pharmacy development in China. Methods The diversification of foreign online pharmacies was studied on the basis of nature analysis of e-commerce development and literature review. Results and Conclusion The study indicates that there are diversified operation forms abroad, such as electronic enterprises, large pharmaceutical chain stores, the non-drug retail stores and the government agencies carrying out the operation of online pharmacies. In order to promote the development of online pharmacies in China, we can learn from the foreign experiences and allow the electronic enterprises, the nondrug retail stores and the government agencies to become the subjects of online pharmacies based on the current situations in China. 相关文章 | 计量指标